Evidence map›Paper›PMID 25585949›Full record

Trial reportRenal failure2015

Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass.

John Richard Prowle, Paolo Calzavacca, Elisa Licari, E Valentina Ligabo, Jorge E Echeverri, Sean M Bagshaw, Anja Haase-Fielitz, Michael Haase, Vaughn Ostland, Eisei Noiri and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Renal failure, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 4 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 4 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Hepcidin and Iron in Health and Disease.Annual review of medicine · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 5 countries.

John Richard ProwleDepartment of Intensive Care, Austin Hospital , Melbourne , Australia .
Paolo Calzavacca
Elisa Licari
E Valentina Ligabo
Jorge E Echeverri
Sean M Bagshaw
Anja Haase-Fielitz
Michael Haase
Vaughn Ostland
Eisei Noiri
Mark Westerman
Prasad Devarajan
Rinaldo Bellomo
Austin Hospital · AUIntrinsic LifeSciences (United States) · USOtto-von-Guericke University Magdeburg · DECincinnati Children's Hospital Medical Center · USUniversity of Alberta · CAUniversity of Tokyo Hospital · JP

Funding

Proteomics CoreP50DK096418 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI DEVARAJAN, PRASAD · 2012 to 2021
$8.4M
NIDDK NIH HHS P50 DK096418
6 · The paper itself

Abstract

Novel acute kidney injury (AKI) biomarkers offer promise of earlier diagnosis and risk stratification, but have yet to find widespread clinical application. We measured urinary α and π glutathione S-transferases (α-GST and π-GST), urinary l-type fatty acid-binding protein (l-FABP), urinary neutrophil gelatinase-associated lipocalin (NGAL), urinary hepcidin and serum cystatin c (CysC) before surgery, post-operatively and at 24 h after surgery in 93 high risk patient undergoing cardiopulmonary bypass (CPB) and assessed the ability of these biomarkers alone and in combination to predict RIFLE-R defined AKI in the first 5 post-operative days. Twenty-five patients developed AKI. π-GST (ROCAUC = 0.75), lower urine Hepcidin:Creatine ratio at 24 h (0.77), greater urine NGAL:Cr ratio post-op (0.73) and greater serum CysC at 24 h (0.72) best predicted AKI. Linear combinations with significant improvement in AUC were: Hepcidin:Cr 24 h + post-operative π-GST (AUC = 0.86, p = 0.01), Hepcidin:Cr 24 h + NGAL:Cr post-op (0.84, p = 0.03) and CysC 24 h + post-operative π-GST (0.83, p = 0.03), notably these significant biomarkers combinations all involved a tubular injury and a glomerular filtration biomarker. Despite statistical significance in receiver-operator characteristic (ROC) analysis, when assessed by ability to define patients to two groups at high and low risk of AKI, combinations failed to significantly improve classification of risk compared to the best single biomarkers. In an alternative approach using Classification and Regression Tree (CART) analysis a model involving NGAL:Cr measurement post-op followed by Hepcidin:Cr at 24 h was developed which identified high, intermediate and low risk groups for AKI. Regression tree analysis has the potential produce models with greater clinical utility than single combined scores.

Indexed as

Acute Kidney InjuryBiomarkersPostoperative ComplicationsAcute-Phase ProteinsCardiopulmonary BypassCystatin CEarly DiagnosisFatty Acid-Binding ProteinsFemaleGlutathione TransferaseHepcidinsHumansLipocalin-2LipocalinsMalePredictive Value of TestsAcute-Phase ProteinsBiomarkersCystatin CFatty Acid-Binding ProteinsGlutathione TransferaseHepcidinsLCN2 protein, humanLipocalin-2LipocalinsProto-Oncogene ProteinsAcute kidney injurybiomarkerscardiac bypassglutathione S-transferasehepcidinliver fatty acid binding proteinneutrophil gelatinase associated lipocalin

Identifiers

PMID25585949
PMCPMC4544762
OpenAlexW2038699263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.